Starpharma Holdings Ltd has released a press release.
Partnered Program Update
Filed with ASX ·
6ix hasn’t read this filing yet.
Starpharma Holdings Limited on 6ix
Earlier from Starpharma
- Trading Halt
- Pause in Trading
- Starpharma partners with UQ to advance DEP radio pipeline
- DEP HER2-radiodiagnostic shows imaging benefits
- Clinical Trial Update
Later from Starpharma
- SPL to receive $6.5M from Mundipharma and VivaGel BV rights
- App 4E/Annual Report to shareholders
- Positive DEP irinotecan clinical results presentation
- VIRALEZ UK COVID-19 Clinical Study Completes Recruitment
- DEP irinotecan combination data presentation
Follow Starpharma into a list and get an email when it puts out news.
Follow Starpharma